We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Hologic Inc (HOLX) Com Stk USD0.01

Sell:$74.81 Buy:$74.82 Change: $0.41 (0.55%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Change: $0.41 (0.55%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Change: $0.41 (0.55%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.

Contact details

250 Campus Drive
United States
+1 (508) 2632900

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$17.47 billion
Shares in issue:
233.38 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Stephen Macmillan
    Chairman of the Board, President, Chief Executive Officer
  • Karleen Oberton
    Chief Financial Officer
  • Erik Anderson
    Division President - Breast and Skeletal Health Solutions
  • Jennifer Schneiders
    President - Diagnostic Solutions
  • Brandon Schnittker
    Division President, GYN Surgical Solutions
  • Jan Verstreken
    Group President - International
  • Essex Mitchell
    Chief Operating Officer
  • Peter Dunne
    Senior Vice President - Human Resources
  • John Griffin
    General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.